Log In
BCIQ
Print this Print this
 

LCB01-0371

  Manage Alerts
Collapse Summary General Information
Company LegoChem Biosciences Inc.
DescriptionSecond generation oxazolidinone antibiotic
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationGram-positive bacterial infection
Indication DetailsTreat Gram-positive bacterial infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today